Vericel Corporation (VCEL)
Nasdaq: VCEL · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 1996
Grade7.2
◀ Past 7.4● Present 8.1▶ Future 5.7
Who owns Vericel Corporation
As filed with the SECHolders of 5% or more
3
Blackrock, Inc. holds 15.1% of Common Stock, as its SCHEDULE 13G/A filed Apr 30, 2025 says.
Directors and officers
13
report now, of 17 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 30, 2025 · Common Stock
State Street Corporation
SCHEDULE 13G · filed Nov 10, 2025 · COMMON STOCK
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Brown Capital Management, LLC
SCHEDULE 13G/A · filed Nov 12, 2025 · Common Stock, No Par Value Per Share · reported falling below 5%, from 6.56% in May 15, 2025
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, no par value per share · reported falling below 5%, from 5% in Apr 1, 2026
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What VCEL reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Feb 26, 2026.
Insider tradesForm 4
44sales
0purchases
40sales on a scheduled plan
9people selling
$13.0Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mara Joseph Anthony Jr | Chief Financial Officer | 8 | $4.6M | 8 | 0 | $0 |
| Flynn Sean C. | Chief Legal Officer | 5 | $2.8M | 5 | 0 | $0 |
| Halpin Michael | Chief Operating Officer | 4 | $1.6M | 4 | 0 | $0 |
| Mclaughlin Kevin F | director | 5 | $1.2M | 5 | 0 | $0 |
| Hopper Jonathan Mark | Chief Medical Officer | 5 | $800,000 | 5 | 0 | $0 |
| Siegal Jonathan | Principal Accounting Officer | 8 | $600,000 | 8 | 0 | $0 |
| Wotton Paul K | director | 4 | $500,000 | 0 | 0 | $0 |
| Hagen Heidi | director | 1 | $500,000 | 1 | 0 | $0 |
| Zerbe Robert L Md | director | 4 | $400,000 | 4 | 0 | $0 |